Name: Latest research reports of Natco Pharma Ltd. authored by Edelweiss and published by - Trendlyne research reports.
Item: Natco Pharma Ltd.
Rating: 3
Author: Edelweiss

Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Strong Performer, Under Radar

869.2000 -5.90 (-0.67%)

NSE Jun 23, 2025 15:31 PM

46.97% Fall from 52W High

Volume: 353.3K

Natco Pharma Ltd.

06 Nov 2017

869.20

-0.67%

Natco Pharmaceuticals Limited - Result Update Q2FY18

Hold: Natco Pharma Ltd.

Recommendation Target

Edelweiss

Natco Pharmaceuticals Limited (NATCO) Q2FY18: Underperformance led by pricing pressure across; exciting launches ahead.

Geojit BNP Paribas increased Hold price target of Natco Pharma Ltd. to 952.0 on 11 Jun, 2025.